Pulmonary Hypertension and Atrial Septal Defect: Management Dilemma

Karim El-Kersh, Molly Howsare, Ali Zaidi, Michael P. Flaherty, J. Shaun Smith

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


The decision making in patients with an atrial septal defect (ASD) in setting of pulmonary hypertension is complex. In the era of pulmonary arterial vasodilator therapy, every patient should undergo evaluation by pulmonary hypertension experts especially if defect closure is being considered. Defect closure in the inappropriate group can lead to poor outcomes.

Original languageEnglish (US)
Pages (from-to)e602-e605
JournalAmerican journal of therapeutics
Issue number5
StatePublished - 2017
Externally publishedYes


  • Amplatzer septal occluder
  • ASD
  • Eisenmenger physiology
  • pulmonary hypertension
  • pulmonary-to-systemic flow (Qp/Qs) ratio

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Pulmonary Hypertension and Atrial Septal Defect: Management Dilemma'. Together they form a unique fingerprint.

Cite this